The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview.

Rubboli, A; Faxon, D P; Juhani Airaksinen, K E; Schlitt, A; Marín, F; Bhatt, D L; Lip, G Y H

Rubboli, A; Faxon, D P; Juhani Airaksinen, K E; Schlitt, A; Marín, F; Bhatt, D L; Lip, G Y H.

Affiliation

Rubboli A; Dr. Andrea Rubboli, FESC, Division of Cardiology, Laboratory of Interventional Cardiology, Ospedale Maggiore, Largo Nigrisoli 2, 40133 Bologna, Italy, Tel.: +39 0516478976, Fax: +39 0516478635, E-mail andrearubboli@libero.it.

Thromb Haemost ; 112(6): 1080-7, 2014 Dec.

Article in En | MEDLINE | ID: mdl-25298351

Subject(s)

Acute Coronary Syndrome/therapy; Anticoagulants/administration & dosage; Coronary Artery Disease/therapy; Percutaneous Coronary Intervention/instrumentation; Stents; Acute Coronary Syndrome/blood; Acute Coronary Syndrome/diagnosis; Administration, Oral; Anticoagulants/adverse effects; Blood Coagulation/drug effects; Coronary Artery Disease/blood; Coronary Artery Disease/diagnosis; Coronary Thrombosis/etiology; Coronary Thrombosis/prevention & control; Drug Administration Schedule; Hemorrhage/chemically induced; Humans; Patient Selection; Percutaneous Coronary Intervention/adverse effects; Platelet Aggregation Inhibitors/administration & dosage; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

Key words

Percutaneous coronary intervention; non-vitamin-K antagonist oral anticoagulants; oral anticoagulation; stent; warfarin

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Coronary Artery Disease / Stents / Acute Coronary Syndrome / Percutaneous Coronary Intervention / Anticoagulants Type of study: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Thromb Haemost Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google